Clinical and laboratory characteristics that differentiate hereditary angioedema in 72 patients with angioedema.

BACKGROUND Hereditary angioedema (HAE) is a rare but life-threatening condition that results from mutations in C1-inhibitor (C1-INH). Since distinguishing HAE from other causes of angioedema (AE) is a critical problem in emergencies, the objective of the present study was to clarify the differences between HAE and other forms of AE. METHODS Seventy-two patients with AE were enrolled in this study. The medical history and laboratory data of patients with HAE at the first visit were compared to those with other types of AE. RESULTS Subjects included 23 patients with HAE, 33 with mast cell-mediated AE, 5 with drug-induced AE and 11 with idiopathic AE. The average age of HAE onset (19.5 ± 8.0 years old) was significantly lower than in other groups. A family history of AE was noted in 82.6% of HAE patients, which was significantly higher than other groups. Swelling affecting the extremities and gastrointestinal (GI) tract was observed in the majority (60 to 80%) of HAE patients. Life threatening laryngeal edema was observed in 30.4% of HAE patients. In 95.6% of HAE patients serum levels of C4 were less than the lower limit of the normal range. In our subjects, the sensitivity and specificity of low C4 for HAE were 95.6% and 93.8%, respectively. CONCLUSIONS Early onset of AE, positive family history, recurrent AE in the extremities and GI tract, and suffocation are distinctive characteristics of HAE. A low serum level of C4 is a useful marker for making a differential diagnosis of HAE.

[1]  R. Lockey,et al.  [WAO Guideline for the Management of Hereditary Angioedema]. , 2015, Arerugi = [Allergy].

[2]  Y. Tomino,et al.  Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema , 2013, BMC Gastroenterology.

[3]  W. Aberer,et al.  International consensus on hereditary and acquired angioedema. , 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  K. Akashi,et al.  Hereditary Angioedema in Japan: Genetic Analysis of 13 Unrelated Cases , 2012, The American journal of the medical sciences.

[5]  M. Hide,et al.  A large heterozygous deletion including the entire C1 inhibitor gene in a sporadic case of hereditary angio‐oedema , 2012, Clinical and experimental dermatology.

[6]  H. Farkas,et al.  Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency. , 2011, Clinical Immunology.

[7]  ほか,et al.  遺伝性血管性浮腫(hereditary angioedema; HAE)—疾患概要と疾患認知度全国調査—Hereditary angioedema recognition survey in Japan(研究) , 2011 .

[8]  Z. Ikezawa,et al.  [National prevalence survey of hereditary angioedema in Japan]. , 2011, Arerugi = [Allergy].

[9]  A. Marzano,et al.  Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications , 2010, Internal and emergency medicine.

[10]  高萩 俊輔 Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria , 2010 .

[11]  A. Bellatorre,et al.  Plasma biomarkers of acute attacks in patients with angioedema due to C1‐inhibitor deficiency , 2009, Allergy.

[12]  B. Zuraw Clinical practice. Hereditary angioedema. , 2008, The New England journal of medicine.

[13]  B. Zuraw Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new? , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[14]  M. Cicardi,et al.  Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. , 2006, Immunology and allergy clinics of North America.

[15]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[16]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[17]  S. Choquet,et al.  Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema. , 2000, The Journal of allergy and clinical immunology.